Louie Ngar Yee 4
4 · MAIA Biotechnology, Inc. · Filed Mar 15, 2024
Insider Transaction Report
Form 4
Louie Ngar Yee
Director
Transactions
- Purchase
Warrants
2024-03-14$1.30/sh+170,940$222,222→ 170,940 totalExercise: $1.30From: 2024-09-14Exp: 2029-09-14→ Common Stock (170,940 underlying) - Purchase
Common Stock
2024-03-14$1.17/sh+170,940$200,000→ 1,147,524 total
Footnotes (2)
- [F1]The common stock was purchased pursuant to a Securities Purchase Agreement dated March 11, 2024 and were issued under the Issuer's 2021 Equity Incentive Plan on March 14, 2024.
- [F2]The warrants were purchased pursuant to a Securities Purchase Agreement dated March 11, 2024 and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on March 14, 2024. The options are exercisable beginning on the six month anniverary of the issuance date and expire 5-years after the initial exercise date.